First of all, I'm quite long the stock.
Second, it ties in with the approval by the FDA for use of hemopurifier in the USA immediately!
I don't get what you're saying?
Perhaps if I list "Strong Buy" you'll feel better?
Sentiment: Strong Buy
This is going to be used big time in the USA! It's our only hope so far.
See my post on Brooklyn woman this morning ..."Out This Morning!"
It's spreading.....make no mistake about it, and the government is trying hard to keep the cases out of the press. They have received cooperation from the press. (perhaps rightfully so. You don't want to create panic)
Brooklyn Woman On Ebola Monitoring List Drops Dead Bleeding From "Face, Mouth, Nose"
Just a week after Dr. Craig Spencer was declared 'Ebola-free', The Daily Mail reports a woman, who had arrived from Guinea 18 days ago (and was on the NYC Ebola monitoring list), dropped dead in a Brooklyn hair salon this afternoon. FDNY sent their Special Operations and Hazmat units but she was declared dead at the scene. Witnesses said she was bleeding from the "face, nose, mouth, everything."
Based on FDA guidance, Aethlon will now provide Hemopurifier® therapy to treat Ebola infection through expanded access "emergency use" provisions in the United States. Expanded access "emergency use" of an investigational device does not require advance FDA approval for life threatening circumstances for which an alternative therapy is not available. At present, no antiviral therapy or vaccine has proven to be effective against Ebola virus infection in humans.
SAN DIEGO, Nov. 19, 2014 /PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ:OTCQB:AEMD), the pioneer in developing targeted therapeutic devices to address infectious disease and cancer, disclosed today that it will provide Hemopurifier® therapy under FDA expanded access "emergency use" provisions to support requests from qualified physicians and institutes that may seek to treat ebola virus infection in the United States.
I know, idiot!
I'm referring to SeeThr Equity's upgrade this morning.
It was obviously based on that conference.
Aethlon Medical to Present at Tomorrow's SeeThruEquity Conference
SAN DIEGO, Nov. 11, 2014 /PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ:OTCQB:AEMD), the pioneer in developing targeted therapeutic devices to address infectious disease and cancer, announced today that the Company's Chairman and Chief Executive Officer, Jim Joyce, will present at the SeeThruEquity Microcap Investor Forum on Wednesday, November 12th, at 10:00 EST.
I s#$%$id: Looks like the short d#$%$ytr#$%$ders #$%$re st#$%$rting to cover. If th#$%$t's the c#$%$se, we could see #$%$ nice rebound.
Noki#$%$ h#$%$s some of the top IT engineers in the world.
They would h#$%$ve #$%$ field d#$%$y with this.
One word, only one positive word in the next few days, about the hemopurifier, will send this well over .50.
Perhaps to the price target of .74 announced this morning.
Been moving down over the past few hours on very little volume.
Simply nervous investors unloading small lots.
You are so right, a lot of news in the pipeline yet to come.
Wait for most of the news, on their calendar, to be released. You won't regret it.